MedPath

A study to see the effect of kokoila anjana kaphaja timira

Phase 2
Conditions
Health Condition 1: H258- Other age-related cataractHealth Condition 2: H258- Other age-related cataract
Registration Number
CTRI/2021/01/030200
Lead Sponsor
Dr Remya Madhav
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients fulfilling diagnostic criteria (masking vision, glare, object as if covered with a net, blurred vision for distant, visual acuity ranging from 6/9 - 6/60 and diagnosis confirmed by direct ophthalmoscopy and slit lamp)

Patients of age group 40 - 70

Patients of either gender

Patients ready to sign informed consent

Exclusion Criteria

Patients with senile mature and hyper mature cataract

Congenital, developmental, traumatic, complicated, or metabolic cataract and any other ocular pathology that can cause a diminution of vision were excluded from the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical study on the efficacy of kokila anjana in kaphaja timira (senile immature cataract)Timepoint: Clinical study on the efficacy of kokila anjana in kaphaja timira (senile immature cataract)within in 60 days
Secondary Outcome Measures
NameTimeMethod
Delay the preceding stages and to improve and maintain the visionTimepoint: During the treatment-15 the day, 30th day, 45th day and 60th day review <br/ ><br>follow up after the the traetment - 75th day and 90th day
© Copyright 2025. All Rights Reserved by MedPath